Tim Coughlin

Track

Insider profile

Currently holds positions in Fate Therapeutics Inc, Travere Therapeutics Inc and aTyr Pharma Inc

Performance

Overall performance
1.2
Performance over holding periods
1.2
30 days 90 days 120 days
Average return -28% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director Fate Therapeutics Inc Aug. 1, 2013 -
Independent Director Travere Therapeutics Inc March 31, 2015 -
Independent Director aTyr Pharma Inc April 7, 2017 -
Chief Financial Officer, Vice President Neurocrine Biosciences Inc Sept. 1, 2006 - Dec. 31, 2016
Tim Coughlin's trades of Travere Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-16 2026-06-12
PlS Planned sale
89,995 -39.6%
371.30
US$2,651,858 		89,995 -39.6% 371.30 US$2,651,858
2026-06-12 2026-06-12
PrS Proposed sale
18,777
29.50
US$207,486 		18,777 29.50 US$207,486
2026-05-19 2026-05-15
PlS Planned sale
69,435 +47.3%
71.83
US$3,924,519 		69,435 +47.3% 71.83 US$3,924,519
2026-05-15 2026-05-15
PrS Proposed sale
3,250
43.44
US$141,183 		3,250 43.44 US$141,183
2025-11-04 2025-10-31
PlS Planned sale
18,000 -24.5%
35.03
US$630,601 		18,000 -24.5% 35.03 US$630,601
2025-10-31 2025-10-31
PrS Proposed sale
18,000
34.98
US$629,693 		18,000 34.98 US$629,693
2024-06-03 2024-05-30
B Purchase
50,000 +833.3%
1.75
US$87,500 		50,000 +833.3% 1.75 US$87,500
2022-06-06 2022-06-03
S Sale
1,439 -2.4%
22.81
US$32,824 		1,439 -2.4% 22.81 US$32,824
2017-02-08 2017-02-06
PlS Planned sale
963 -0.7%
43.14
US$41,544 		963 -0.7% 43.14 US$41,544
2017-02-06 2017-02-03
PlS Planned sale
1,500 -1.1%
42.55
US$63,825 		1,500 -1.1% 42.55 US$63,825
2017-01-18 2017-01-17
PlS Planned sale
1,750 -1.3%
40.65
US$71,138 		1,750 -1.3% 40.65 US$71,138
2016-02-04 2016-02-03
PlS Planned sale
1,500 -1.1%
38.06
US$57,090 		1,500 -1.1% 38.06 US$57,090
2016-01-21 2016-01-19
PlS Planned sale
1,750 -1.3%
46.69
US$81,708 		1,750 -1.3% 46.69 US$81,708
2016-01-13 2016-01-11
PlS Planned sale
1,750 -1.3%
44.25
US$77,438 		1,750 -1.3% 44.25 US$77,438